The Enterprise Value as of October 2024 (TTM) for VBI Vaccines Inc. (VBIV) is 39.99M

According to VBI Vaccines Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 39.99M. This represents a change of -13.86% compared to the average of 46.43M of the last 4 quarters.

VBI Vaccines Inc. (VBIV) Historical Enterprise Value (quarterly & annually)

How has VBIV Enterprise Value performed in the past?

The mean historical Enterprise Value of VBI Vaccines Inc. over the last ten years is 167.70M. The current 39.99M Enterprise Value has changed 2.28% with respect to the historical average. Over the past ten years (40 quarters), VBIV's Enterprise Value was at its highest in in the June 2021 quarter at 748.28M. The Enterprise Value was at its lowest in in the September 2014 quarter at 2.98M.

VBI Vaccines Inc. (VBIV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of VBI Vaccines Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

VBI Vaccines Inc. (VBIV) Average Enterprise Value

How has VBIV Enterprise Value performed in the past?

The current Enterprise Value of VBI Vaccines Inc. (VBIV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

VBI Vaccines Inc. (VBIV) Enterprise Value vs. Peers

How is VBIV’s Enterprise Value compared to its peers?

VBI Vaccines Inc.’s Enterprise Value is less than Tonix Pharmaceuticals Holding Corp. (0), greater than Onconova Therapeutics, Inc. (24.56M), greater than Jaguar Health, Inc. (4.51M), greater than Vaxart, Inc. (27.72M), less than Allogene Therapeutics, Inc. (144.74M), less than Anixa Biosciences, Inc. (550.88M), less than Akero Therapeutics, Inc. (110.03M), less than Ardelyx, Inc. (1.95B), less than iBio, Inc. (1.45B), greater than GeoVax Labs, Inc. (14.65M), greater than Ocugen, Inc. (13.84M), less than Aurinia Pharmaceuticals Inc. (266.79M), less than Gritstone bio, Inc. (1.08B), less than BridgeBio Pharma, Inc. (54.12M), less than Annovis Bio, Inc. (5.92B), less than ImmunoGen, Inc. (109.96M), less than null (8.19B),

Build a custom stock screener for VBI Vaccines Inc. (VBIV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VBI Vaccines Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

VBI Vaccines Inc. (VBIV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like VBI Vaccines Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.